Keros Therapeutics, Inc. (KROS) Deep Dive Video

Name: Keros Therapeutics, Inc. (KROS) Deep Dive Video | Flash
Uploaded: 2026-02-21T19:46:23.481
Description: A cash-rich, post-tender biotech priced like a shell—despite a legally binding Takeda royalty/milestone engine and a high-upside KER-065 DMD/obesity option.

Summary

A cash-rich, post-tender biotech priced like a shell—despite a legally binding Takeda royalty/milestone engine and a high-upside KER-065 DMD/obesity option.

View KROS stock page · Read the KROS research report

Loading the video player…